Skip to main content
Search
Search
Advanced Search
Skip main navigation
Open access
Clinical Trial Protocol
29 March 2023

Protocol for the implementation of a statewide mobile addiction program

Authors: Cynthia A Tschampl https://orcid.org/0000-0001-8133-4683 [email protected], Craig Regis, Nafissa E Johnson https://orcid.org/0000-0001-5404-7072, Margot Trotter Davis https://orcid.org/0000-0002-5042-1044, Dominic Hodgkin, Mary F Brolin https://orcid.org/0000-0002-0286-4860, Elizabeth Do, Constance M Horgan https://orcid.org/0000-0002-2659-7082, Traci C Green https://orcid.org/0000-0001-9105-6904, Brittni Reilly, MaryKate Duska https://orcid.org/0000-0001-6033-7615, and Elsie M TaverasAuthor Info & Affiliations
Volume 12, Number 5
https://doi.org/10.57264/cer-2022-0117
PDFFormats

Abstract

With overdose deaths increasing, improving access to harm reduction and low barrier substance use disorder treatment is more important than ever. The Community Care in Reach® model uses a mobile unit to bring both harm reduction and clinical care for addiction to people experiencing barriers to office-based care. These mobile units provide many resources and services to people who use drugs, including safer consumption supplies, naloxone, medication for substance use disorder treatment, and a wide range of primary and preventative care. This protocol outlines the evaluation plan for the Community in Care® model in MA, USA. Using the RE-AIM framework, this evaluation will assess how mobile services engage new and underserved communities in addiction services and primary and preventative care.

Supplementary Material

File (supplementary infographic.png)

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Massachusetts Department of Public Health. Data brief: opioid-related overdose deaths among Massachusetts residents (2021). www.mass.gov/doc/opioid-related-overdose-deaths-among-ma-residents-november-2021/download
Google Scholar
2.
Baumgartner JC, Radley DC, The Commonwealth Fund. Thespike in drug overdose deaths during the COVID-19 pandemic and policy options to move forward (2021). www.commonwealthfund.org/blog/2021/spike-drug-overdose-deaths-during-covid-19-pandemic-and-policy-options-move-forward
Google Scholar
3.
Sordo L, Barrio G, Bravo MJ et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. Brit. Med. J. 357, j1550 (2017).
PubMed
Google Scholar
4.
Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J. Addict. Med. 8(3), 153–163 (2014).
PubMed
Google Scholar
5.
Vearrier L. The value of harm reduction for injection drug use: a clinical and public health ethics analysis. Dis. Mon. 65(5), 119–141 (2019).
PubMed
Google Scholar
6.
Shulman M, Wai JM, Nunes EV. Buprenorphine treatment for opioid use disorder: an overview. CNS Drugs 33(6), 567–580 (2019).
PubMed
Google Scholar
7.
Ross LE, Vigod S, Wishart J et al. Barriers and facilitators to primary care for people with mental health and/or substance use issues: a qualitative study. BMC Fam. Pract. 16(1), 135 (2015).
PubMed
Google Scholar
8.
Motavalli D, Taylor JL, Childs E et al. “Health Is on the Back Burner:” multilevel barriers and facilitators to primary care among people who inject drugs. J. Gen. Intern. Med. 36(1), 129–137 (2021).
PubMed
Google Scholar
9.
Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am. J. Drug Alcohol Abuse 45(1), 1–10 (2019).
PubMed
Google Scholar
10.
Fine DR, Lewis E, Weinstock K, Wright J, Gaeta JM, Baggett TP. Office-based addiction treatment retention and mortality among people experiencing homelessness. JAMA Netw. Open 4(3), e210477 (2021).
PubMed
Google Scholar
• Aims to evaluate the retention and mortality in an office-based addiction treatment program setting for a population of homeless individuals with opioid use disorder.
11.
Yu SWY, Hill C, Ricks ML, Bennet J, Oriol NE. The scope and impact of mobile health clinics in the United States: a literature review. Int. J. Equity Health 16(1), 178 (2017).
PubMed
Google Scholar
• Reviews healthcare accessibility through Mobile Health Clinics and their use in reaching vulnerable populations by delivering curbside services.
12.
Stewart J, Stadeli KM, Ásbjörnsdóttir KH et al. Use of a community center primary care clinic and subsequent emergency department visits among unhoused women. JAMA Netw. Open 4(3), e213134 (2021).
PubMed
Google Scholar
13.
Rosecrans A, Harris R, Saxton RE et al. Mobile low-threshold buprenorphine integrated with infectious disease services. J. Subst. Abuse Treat. 133, 108553 (2022).
PubMed
Google Scholar
• This cohort analysis examines patient demographics, services provided and buprenorphine treatment retention for patients receiving care at the Spot mobile clinic, co-located with a Baltimore Syringe services program.
14.
Silberzahn BE, Tomko CA, Clouse E et al. The EMERALD (Enabling Mobilization, Empowerment, Risk Reduction, and Lasting Dignity) Study: protocol for the design, implementation, and evaluation of a community-based combination HIV prevention intervention for female sex workers in Baltimore, Maryland. JMIR Res. Protoc. 10(4), e23412 (2021).
PubMed
Google Scholar
• Examines the design, implementation and planned evaluation of a community led intervention to improve the HIV and STI incidence among female sex workers. The main components of the intervention included the SPARC (sex workers promoting action, risk reduction, and community mobilization), meant to provide low barrier harm reduction services and the mobile outreach component.
15.
Westfall JM, Nease DE, Zittleman L. Mobile van medication-assisted treatment for opioid use disorder is not enough (2022). www.healthaffairs.org/do/10.1377/forefront.20220222.646538
Google Scholar
16.
Regis C, Gaeta JM, Mackin S, Baggett TP, Quinlan J, Taveras EM. Community care in reach: mobilizing harm reduction and addiction treatment services for vulnerable populations. Front. Public Health 8 (2020). https://www.frontiersin.org/article/10.3389/fpubh.2020.00501
PubMed
Google Scholar
•• Explores the Community Care in Reach mobile van, which addresses the prevalence of opioid overdoses in Greater Boston among vulnerable populations, and individuals experiencing homelessness. The Community Care in Reach Program provides harm reduction services, addiction treatment and primary care.
17.
Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, MD, USA (2018). www.samhsa.gov/data/
Google Scholar
18.
Green TC, Park JN, Gilbert M et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int. J. Drug Policy 77, 102661 (2020).
PubMed
Google Scholar
19.
Glick JL, Christensen T, Park JN, McKenzie M, Green TC, Sherman SG. Stakeholder perspectives on implementing fentanyl drug checking: results from a multi-site study. Drug Alcohol Depend. 194, 527–532 (2019).
PubMed
Google Scholar
20.
Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int. J. Drug Policy 68, 46–53 (2019).
PubMed
Google Scholar
21.
Rudolph L, Maizlish N, North S, Dervin K. A public health learning collaborative on climate change for Urban Health Departments, 2016–2018. Public Health Rep. 135(2), 189–201 (2020).
PubMed
Google Scholar
22.
Weinberger A, Stegmann K, Fischer F. Knowledge convergence in collaborative learning: concepts and assessment. Learn. Instr. 17(4), 416–426 (2007).
Google Scholar
23.
Keck C, Hartley DM, Havens M, Margolis PA, Seid M. Getting what is needed, when it's needed: sharing information, knowledge, and know-how in a Collaborative Learning Health System. Learn. Health Syst. 5(3), e10268 (2021).
PubMed
Google Scholar
24.
Nicholson J, English K, Heyman M. The Parenting Well Learning Collaborative Feasibility Study: training adult mental health service practitioners in a family-focused practice approach. Community Ment. Health J. 58(2), 261–276 (2022).
PubMed
Google Scholar
25.
Cannon-Bowers JA, Salas E. Reflections on shared cognition. J. Organ Behav. 22(2), 195–202 (2001).
Google Scholar
26.
Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am. J. Public Health 89(9), 1322–1327 (1999).
PubMed
Google Scholar
27.
Shelton RC, Chambers DA, Glasgow RE. An extension of RE-AIM to enhance sustainability: addressing dynamic context and promoting health equity over time. Front. Public Health 8, 134 (2020).
PubMed
Google Scholar
28.
Glasgow RE, Estabrooks PE. Pragmatic applications of RE-AIM for health care initiatives in community and clinical settings. Prev. Chronic. Dis. 15, E02 (2018).
PubMed
Google Scholar
•• Aims to examine the use of the RE-AIM model to evaluate public health interventions that aim to assess reach, efficacy, adoption, implementation and maintenance.
29.
Simon C, Brothers S, Strichartz K et al. We are the researched, the researchers, and the discounted: the experiences of drug user activists as researchers. Int. J. Drug Policy 98, 103364 (2021).
PubMed
Google Scholar
30.
Greater Lawrence Family Health Center. Health care on the road the importance of GLFHC's new Mobile Health Unit. InPulse 1(7), 8 (2017).
Google Scholar
31.
Mirer AG, Tiemstra JD, Hammes NE, Cloum HM, LaFavor KJ. Integrating buprenorphine treatment for opioid use with primary care is associated with greater retention in treatment. J. Am. Board Fam. Med. 35(1), 206–208 (2022).
PubMed
Google Scholar
|